Your browser doesn't support javascript.
loading
Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains.
Chrysostomou, Andreas C; Topcu, Cicek; Stylianou, Dora C; Hezka, Johana; Kostrikis, Leondios G.
Afiliação
  • Chrysostomou AC; Department of Biological Sciences, University of Cyprus, 1 University Avenue, Aglantzia 2109, Nicosia, Cyprus.
  • Topcu C; Department of Biological Sciences, University of Cyprus, 1 University Avenue, Aglantzia 2109, Nicosia, Cyprus.
  • Stylianou DC; Department of Biological Sciences, University of Cyprus, 1 University Avenue, Aglantzia 2109, Nicosia, Cyprus.
  • Hezka J; Department of Biological Sciences, University of Cyprus, 1 University Avenue, Aglantzia 2109, Nicosia, Cyprus.
  • Kostrikis LG; Department of Biological Sciences, University of Cyprus, 1 University Avenue, Aglantzia 2109, Nicosia, Cyprus. Electronic address: lkostrik@ucy.ac.cy.
Infect Genet Evol ; 81: 104243, 2020 07.
Article em En | MEDLINE | ID: mdl-32061896
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Infecções por HIV / HIV-1 / Inibidores da Transcriptase Reversa / Inibidores de Integrase / Farmacorresistência Viral Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Infecções por HIV / HIV-1 / Inibidores da Transcriptase Reversa / Inibidores de Integrase / Farmacorresistência Viral Idioma: En Ano de publicação: 2020 Tipo de documento: Article